Does MACITENTAN Cause Pulmonary arterial hypertension? 2,390 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,390 reports of Pulmonary arterial hypertension have been filed in association with MACITENTAN (OPSYNVI). This represents 5.3% of all adverse event reports for MACITENTAN.
2,390
Reports of Pulmonary arterial hypertension with MACITENTAN
5.3%
of all MACITENTAN reports
1,204
Deaths
1,695
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From MACITENTAN?
Of the 2,390 reports, 1,204 (50.4%) resulted in death, 1,695 (70.9%) required hospitalization, and 111 (4.6%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 2,390 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)
BOSENTAN\BOSENTAN (245)
Which MACITENTAN Alternatives Have Lower Pulmonary arterial hypertension Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE